Fungal infection in cerebrospinal fluid from some patients with multiple sclerosis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 32, Issue 6, 2013, Pages 795-801

  Pisa, D ^a   Alonso, R ^a   Jimenez Jimenez F J ^b   Carrasco, L ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Hospital Universitario del Sureste de Madrid   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGAL DNA; FUNGUS ANTIBODY; FUNGUS ANTIGEN;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ANTIGEN DETECTION; ARTICLE; BLOOD ANALYSIS; CANDIDA ALBICANS; CANDIDA FAMATA; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; HUMAN; IMMUNOREACTIVITY; MALASSEZIA GLOBOSA; MALE; MULTIPLE SCLEROSIS; MYCOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHODOTORULA MUCILAGINOSA; RISK FACTOR;

ADULT; ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; CANDIDA; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYCOSES; YOUNG ADULT;

EID: 84878240363     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1810-8     Document Type: Article

References (38)

1. Barnett MH, Sutton I (2006) The pathology of multiple sclerosis: a paradigm shift. Curr Opin Neurol 19(3):242-247
2. Hawker K (2011) Progressive multiple sclerosis: characteristics and management. Neurol Clin 29(2):423-434
3. Stadelmann C (2011) Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications. Curr Opin Neurol 24(3):224-229
4. Burrell AM, Handel AE, Ramagopalan SV, Ebers GC, Morahan JM (2011) Epigenetic mechanisms in multiple sclerosis and the major histocompatibility complex (MHC). Discov Med 11(58):187-196
5. Giovannoni G, Ebers G (2007) Multiple sclerosis: the environment and causation. Curr Opin Neurol 20(3):261-268
6. Holmoy T, Harbo H, Vartdal F, Spurkland A (2009) Genetic and molecular approaches to the immunopathogenesis of multiple sclerosis: an update. Curr Mol Med 9(5):591-611
7. Kakalacheva K, Munz C, Lunemann JD (2011) Viral triggers of multiple sclerosis. Biochim Biophys Acta 1812(2):132-140
8. Marrie R (2011) Demographic, genetic, and environmental factors that modify disease course. Neurol Clin 29(2):323-341
9. Van der Mei IA, Simpson S Jr, Stankovich J, Taylor BV (2011) Individual and joint action of environmental factors and risk of MS. Neurol Clin 29(2):233-255
10. Goverman JM (2011) Immune tolerance in multiple sclerosis. Immunol Rev 241(1):228-240
11. Hollifield RD, Harbige LS, Pham-Dinh D, Sharief MK (2003) Evidence for cytokine dysregulation in multiple sclerosis: peripheral blood mononuclear cell production of pro-inflammatory and anti-inflammatory cytokines during relapse and remission. Autoimmunity 36(3):133-141
12. McCoy L, Tsunoda I, Fujinami RS (2006) Multiple sclerosis and virus induced immune responses: autoimmunity can be primed by molecular mimicry and augmented by bystander activation. Autoimmunity 39(1):9-19
13. Westall FC (2006) Molecular mimicry revisited: gut bacteria and multiple sclerosis. J Clin Microbiol 44(6):2099-2104
14. Kuhle J, Pohl C, Mehling M, Edan G, Freedman MS, Hartung HP, Polman CH, Miller DH, Montalban X, Barkhof F, Bauer L, Dahms S, Lindberg R, Kappos L and Sandbrink R (2007) Lack of association between antimyelin antibodies and progression to multiple sclerosis. N Engl J Med 356(4):371-378
15. Kutzelnigg A, Lucchinetti CF, Stadelmann C, Bruck W, Rauschka H, Bergmann M, Schmidbauer M, Parisi JE, Lassmann H (2005) Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128(Pt 11):2705-2712
16. D'Haeseleer M, Cambron M, Vanopdenbosch L, De Keyser J (2011) Vascular aspects of multiple sclerosis. Lancet Neurol 10(7):657-666
17. Carrasco L, Ramos M, Galisteo R, Pisa D, Fresno M, Gonzalez ME (2005) Isolation of Candida famata from a patient with acute zonal occult outer retinopathy. J Clin Microbiol 43(2):635-640
18. Pisa D, Ramos M, Garcia P, Escoto R, Barraquer R, Molina S, Carrasco L (2008) Fungal infection in patients with serpiginous choroiditis or acute zonal occult outer retinopathy. J Clin Microbiol 46(1):130-135
19. Gass JD (2003) Are acute zonal occult outer retinopathy and the white spot syndromes (AZOOR complex) specific autoimmune diseases? Am J Ophthalmol 135(3):380-381
20. Heckenlively JR, Ferreyra HA (2008) Autoimmune retinopathy: a review and summary. Semin Immunopathol 30(2):127-134
21. Jacobson DM (1996) Acute zonal occult outer retinopathy and central nervous system inflammation. J Neuroophthalmol 16(3):172-177
22. Monson DM, Smith JR (2011) Acute zonal occult outer retinopathy. Surv Ophthalmol 56(1):23-35
23. Benito-León J, Pisa D, Alonso R, Calleja P, Díaz- Sánchez M, Carrasco L (2010) Association between multiple sclerosis and Candida species: evidence from a case-control study. Eur J Clin Microbiol Infect Dis:1139-1145
24. Ramos M (2007) Diagnóstico de candidiasis mediante técnicas de PCR y de detección de antígenos fúngicos. Facultad de Ciencias. Universidad Autónoma de Madrid, Madrid
25. Pisa D, Ramos M, Molina S, Garcia P, Carrasco L (2007) Evolution of antibody response and fungal antigens in the serum of a patient infected with Candida famata. J Med Microbiol 56(Pt 5):571-578
26. Purzycki CB, Shain DH (2010) Fungal toxins and multiple sclerosis: a compelling connection. Brain Res Bull 82(1-2):4-6
27. Malcus-Vocanson C, Giraud P, Broussolle E, Perron H, Mandrand B, Chazot G (1998) A urinary marker for multiple sclerosis. Lancet 351(9112):1330
28. Avni T, Leibovici L, Paul M (2011) PCR diagnosis of invasive candidiasis: systematic review and meta-analysis. J Clin Microbiol 49(2):665-670
29. Bretagne S, Costa JM (2005) Towards a molecular diagnosis of invasive aspergillosis and disseminated candidosis. FEMS Immunol Med Microbiol 45(3):361-368
30. Khan ZU, Mustafa AS (2001) Detection of Candida species by polymerase chain reaction (PCR) in blood samples of experimentally infected mice and patients with suspected candidemia. Microbiol Res 156(1):95-102
31. Gilden DH (2005) Infectious causes of multiple sclerosis. Lancet Neurol 4(3):195-202
32. Giovannoni G, Cutter GR, Lunemann J, Martin R, Munz C, Sriram S, Steiner I, Hammerschlag MR, Gaydos CA (2006) Infectious causes of multiple sclerosis. Lancet Neurol 5(10):887-894
33. Wingerchuk DM (2011) Environmental factors in multiple sclerosis: Epstein-Barr virus, vitamin D, and cigarette smoking. Mt Sinai J Med NY 78(2):221-230
34. Cermelli C, Jacobson S (2000) Viruses and multiple sclerosis. Viral Immunol 13(3):255-267
35. Pisa D, Alonso R, Carrasco L (2011) Fungal infection in a patient with multiple sclerosis. Eur J Clin Microbiol Infect Dis 30(10):1173-1180
36. Rieger F, Amouri R, Benjelloun N, Cifuentes-Diaz C, Lyon-Caen O, Hantaz-Ambroise D, Dobransky T, Perron H, Gemy C (1996) Gliotoxic factor and multiple sclerosis. CR Acad Sci 319(4):343-350
37. Wu GF, Alvarez E (2011) The immunopathophysiology of multiple sclerosis. Neurol Clin 29(2):257-278
38. Gutwinski S, Erbe S, Munch C, Janke O, Muller U, Haas J (2010) Severe cutaneous Candida infection during natalizumab therapy in multiple sclerosis. Neurology 74(6):521-523